In the last two decades the treatment of ovarian and endometrial
carcinomas has achieved tremendous progress thanks also to the
implementation of multidisciplinary boards and to the progress of
knowledge of molecular biology.
These seminars will discuss the state of the art in the treatment of ovarian
and endometrial carcinomas and the new horizons of therapy. Particular
attention will be paid to the asperts connected with virtual multidisciplinarity
and the management of patients, aspects of these current issues in the field
of Covid-19 panepidemic. This multidisciplinary approach plays a pivotal role
in the management of women affected by ovarin or endometrial cancer since
referral to high-volume oncological center is to date mandatory to assure
Furthermore the impact of new knowledge on the molecular biology of these
neoplasms will be discussed in depth.
Prof. Giovanni Scambia, Prof. Vito Chiantera, Prof. Vittorio Gebbia, Prof. Jalid Sehouli